NCT00924443View on ClinicalTrials.gov

A Study of Clofarabine in Older Patients With Acute Myeloid Leukemia (AML) for Whom Chemotherapy Is Not Suitable

PHASE2CompletedINTERVENTIONAL

Enrollment

69

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

June 30, 2006

Study Completion Date

March 31, 2008

Conditions

Acute Myeloid Leukemia

Interventions

DRUG

clofarabine

Trial Locations (15)

Unknown

Dublin

Bologna

Rome

Belfast

Aberdeen

Birmingham

Cardiff

Edinburgh

Leicester

Liverpool

London

Manchester

Nottingham

Somerset

Taunton

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Bioenvision

INDUSTRY

lead

Genzyme, a Sanofi Company

INDUSTRY

NCT00924443 - A Study of Clofarabine in Older Patients With Acute Myeloid Leukemia (AML) for Whom Chemotherapy Is Not Suitable | Biotech Hunter | Biotech Hunter